While rapid antigen tests have always been less accurate than molecular PCR tests, many Americans have relied on them for their convenience to determine if they’re at risk of spreading the virus
Photo: Brittany Murray/MediaNews Group/Long Beach Press-Telegram via Getty Images Now that the American capacity for COVID testing has been overwhelmed by Omicron, it’s a bit of an inopportune time for the Food and Drug Administration to acknowledge that many of the tests people are relying on to know if they have the virus may not be so helpful at detecting the more transmissible variant.
The announcement was made after preliminary studies by the National Institutes of Health’s Rapid Acceleration of Diagnostics found that antigen tests are still able to detect Omicron in samples containing live virus, but are not as reliable as they had been with other strains of the virus. While rapid tests have always been less accurate than molecular PCR tests, many Americans have relied on them for their convenience to determine if they’re at risk of spreading the virus. With the apparent decline in efficacy, the FDA advises that the public “closely follow the tests’ instructions,” by administering two consecutive tests over a period of time, as directed, rather than relying on a one-off negative.
The FDA warning on Tuesday is one of several changes instituted by public-health officials in recent weeks as the nation struggles to figure out how to manage the latest wave of the pandemic; just last week, a different NIH study showed that antigen tests could detect Omicron “with similar” performance to other strains of the virus.
The FDA’s adjusted expectations for antigen tests is not great news for a White House that is already playing catch-up with the latest virus strain. Last week, President Joe Biden announced that the federal government would purchase 500 million antigen tests, though it could take weeks for the order to go through. With the decreased efficacy of the at-home antigen tests, a whole lot more may be needed.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA: Rapid Tests May Not Be the Best at Detecting OmicronThe FDA warned Tuesday that those relying on a rapid test to see if they’ve contracted COVID-19 should double down on them.
Weiterlesen »
The FDA Has Approved Abortion Pills by MailHere’s what you should know about medication abortion.
Weiterlesen »
FDA-approved Vuity eyedrops could replace your reading glassesHow do Vuity eyedrops work? How much do they cost? Experts discuss what consumers should know about FDA-approved product.
Weiterlesen »
High demand, low supply postpones 'miracle' FDA-approved weight loss drug to mid-2022The first FDA-approved weight loss drug since 2014 will not be available to consumers due to manufacturing and delivery issues.
Weiterlesen »
Tom Walker says he owes Kate Middleton royalties after their incredible duetThe number 1 album selling musician has seen his song For Those Who Can’t Be Here rocket 57 places up the charts since he performed the track with the Duchess of Cambridge for an ITV Christmas special
Weiterlesen »